Conclusions
In this pilot study, we provide evidence for de novo and
inherited SNVs relevant to pregnancy loss. Our findings provide
justification for conducting WGS using larger numbers of families and
warrant validation by targeted sequencing to ascertain causal variants.
Elucidating genes causing pregnancy loss may facilitate the development
of risk stratification strategies and novel therapeutics.